CN112641427A - System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks - Google Patents
System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks Download PDFInfo
- Publication number
- CN112641427A CN112641427A CN202010937516.4A CN202010937516A CN112641427A CN 112641427 A CN112641427 A CN 112641427A CN 202010937516 A CN202010937516 A CN 202010937516A CN 112641427 A CN112641427 A CN 112641427A
- Authority
- CN
- China
- Prior art keywords
- module
- data
- contrast agent
- iodine
- iodine contrast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title claims abstract description 115
- 229910052740 iodine Inorganic materials 0.000 title claims abstract description 115
- 239000011630 iodine Substances 0.000 title claims abstract description 115
- 239000002872 contrast media Substances 0.000 title claims abstract description 94
- 238000001727 in vivo Methods 0.000 title claims abstract description 16
- 230000004060 metabolic process Effects 0.000 title claims description 9
- 230000002265 prevention Effects 0.000 claims abstract description 53
- 230000005540 biological transmission Effects 0.000 claims abstract description 34
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 238000011156 evaluation Methods 0.000 claims abstract description 10
- 230000002503 metabolic effect Effects 0.000 claims abstract description 9
- 238000005516 engineering process Methods 0.000 claims description 23
- 238000007405 data analysis Methods 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 12
- 238000004458 analytical method Methods 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000011573 trace mineral Substances 0.000 claims description 6
- 235000013619 trace mineral Nutrition 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 241001474374 Blennius Species 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- SWJBITNFDYHWBU-UHFFFAOYSA-N [I].[I] Chemical compound [I].[I] SWJBITNFDYHWBU-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 230000003044 adaptive effect Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 150000001875 compounds Chemical group 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000000446 fuel Substances 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- SRPSOCQMBCNWFR-UHFFFAOYSA-N iodous acid Chemical compound OI=O SRPSOCQMBCNWFR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004973 liquid crystal related substance Substances 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000004171 remote diagnosis Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000012552 review Methods 0.000 claims description 2
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 208000009079 Bronchial Spasm Diseases 0.000 description 2
- 208000014181 Bronchial disease Diseases 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4866—Evaluating metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Computer Networks & Wireless Communication (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses a system for in vivo metabolic evaluation and risk prevention of an iodine contrast agent. The iodine contrast agent risk prevention system comprises an iodine contrast agent risk prevention system, a power supply module, a data input module, a data recording module I, a data sending module, a wireless transmission module, an information receiving end, a terminal display module and a control module, and is characterized in that: the input of iodine contrast agent risk prevention system is connected with power module's output, the input of data record module one is connected with the output of iodine contrast agent risk prevention system, the input of data transmission module is connected with the output of data record module one, wireless transmission module's input is connected with the output of data transmission module, wireless transmission module cooperation iodine contrast agent detection module and iodine contrast agent risk prevention system's use, make people and medical personnel can be timely monitor and risk prevention the internal iodine contrast agent content, do not need the manual work to detect it, medical personnel's work burden has been reduced.
Description
Technical Field
The invention belongs to the technical field of iodine contrast agents, and particularly relates to an in-vivo metabolism evaluation and risk prevention system for an iodine contrast agent.
Background
The contrast agent refers to some special substances which are often required to be applied in clinical examination and treatment in order to increase the contrast of certain internal organ tissues or cavities and to more clearly show the shapes, contours and pathological features of organs or cavities, and is also called as a contrast agent. The Contrast agent is often a drug containing iodine at various concentrations, and we refer to it as iodine-containing Contrast Agents (ICAs). Adverse reactions caused by contrast agents have been of widespread concern, with common adverse reactions including nausea, vomiting and urticaria. Further progression of urticaria can cause systemic reactions such as hypotension, transient mild secondary tachycardia, vasovagal response, and mild bronchospasm. Severe reactions including hypotensive vagal responses, moderate and severe bronchospasm, laryngeal (tracheal) edema, seizures, severe hypotension and anaphylactic shock, especially latent congestive heart failure, may also cause pulmonary edema. Serious adverse reactions, although occurring at a low rate, can be life threatening.
However, the content of the common iodine contrast agent can be recorded and informed only by manual work, so that the working efficiency is reduced, the labor burden of medical staff is increased, and meanwhile, the time for the patient to know the information is later, and the patient is not favorable for taking treatment measures for the state of an illness in time.
Disclosure of Invention
The invention aims to: in order to solve the problems proposed above, a system for in vivo metabolic evaluation and risk prevention of iodine contrast agents is provided.
The technical scheme adopted by the invention is as follows: the utility model provides a be used for internal metabolism of iodine contrast agent to assess and risk prevention system, includes iodine contrast agent risk prevention system, power module, data input module, data record module one, data transmission module, wireless transmission module, information receiving terminal, terminal display module, control module, its characterized in that: the input end of the iodine contrast agent risk prevention system is connected with the output end of the power supply module, the input end of the first data recording module is connected with the output end of the iodine contrast agent risk prevention system, the input end of the data sending module is connected with the output end of the first data recording module, the input end of the wireless transmission module is connected with the output end of the data sending module, the input end of the information receiving end is connected with the output end of the wireless transmission module, the input end of the terminal display module is connected with the output end of the information receiving end, and the input end of the iodine contrast agent risk prevention system is connected with the output ends;
the iodine contrast agent risk prevention system is provided with an iodine contrast agent detection module, a data analysis module, a data recording module II and a data output end in the inside, the input end of the data output end is connected with the output end of the data recording module II, the input end of the data recording module II is connected with the output end of the data analysis module, and the input end of the data analysis module is connected with the output end of the iodine contrast agent detection module.
In a preferred embodiment, the iodine contrast agent analyzer of the internal social resource of the iodine contrast agent risk prevention system can analyze the iodine contrast agent in the human body; iodine is a necessary trace element of a human body, and the content of the iodine element in the human body directly influences the health of the human body; iodine is an essential trace element of a human body, is one of halogen elements, has the weakest chemical activity in the halogen elements, can be directly combined with most elements, and widely exists in the nature in a compound form; iodine is slightly soluble in water, and stable hypoiodic acid generated by hydrolysis can make a brown yellow aqueous solution acidic; iodine is easily dissolved in organic solvents such as ethanol, diethyl ether, glycerol, etc.; the iodine is blue when meeting starch, so that qualitative and quantitative detection can be carried out; the iodine contrast agent in the seaweed is most abundant and is a main raw material for extracting pure iodine; iodine is also derived from algae in industry, and is mainly used in medicine, fuel, photosensitive material, chemical reagent, etc.
In a preferred embodiment, a data acquisition and recording module adopting an RS232 serial port anti-SD card is arranged in the data recording module I; storing and analyzing; the weighing instrument is used for data acquisition, storage and analysis; the SD card data acquisition and recording module is very convenient to use, only a single chip microcomputer, a PLC or other instrument equipment with an RS232 communication function is needed to send a command string consisting of a string of ASCII codes to the module plus a field data string to be recorded in the SD card, and data are recorded in the SD card of the module; the data records recorded in the SD card are stored in a TXT file format, each record is a line, and each line of data is stored in a predefined fixed format; the TXT file can be copied to a computer for review, reading and analysis.
In a preferred embodiment, a UPS power supply module is arranged inside the power supply module, and an Uninterruptible Power Supply (UPS) is a high-reliability and high-performance power supply which is necessary for a computer, a communication system and occasions requiring uninterrupted supply; the input of alternating current commercial power is changed into direct current through a rectifier, one part of energy is charged to a storage battery pack, the other part of energy is changed into alternating current through an inverter, and the alternating current is transmitted to a load through a change-over switch; in order to still provide energy for the load when the inverter fails, the other path of standby power supply is realized through a power supply changeover switch; modern UPS generally adopts pulse width modulation technology and modern power electronic devices such as power M0SFET, IGBT and the like, so that the noise of a power supply is reduced, and the efficiency and the reliability are improved; the introduction of the microprocessor software and hardware technology can realize intelligent management of the UPS, and remote maintenance and remote diagnosis.
In a preferred embodiment, a wireless SmartAir transmission technology is adopted in the wireless transmission module, and is the only single-antenna mode gigabit wireless high-speed transmission technology in the communication industry; the method adopts the multiband OFDM air interface technology, the TDMA low-delay scheduling technology, the low-density parity check code LDPC, the adaptive modulation coding AMC, the hybrid automatic repeat HARQ and other advanced wireless communication technologies to realize the transmission rate reaching 1 Gbps.
In a preferred embodiment, a data display screen and operation keys are fixedly installed outside the terminal display module, and a liquid crystal module, a control panel and an inverter are arranged inside the data display screen, wherein the control panel plays a role in signal conversion; converting signals of various input formats into signals of a fixed output format; for example, the screen input signal for 1024x768 may be 640 x 480, 800 x 600, 1024x768, etc., ultimately converted to an output format of 1024x 768.
In a preferred embodiment, the inside of the information receiving end includes a receiving end used by medical staff and a mobile information receiving end used by patients, and the receiving end can be a mobile phone, an electronic computer, a tablet computer and the like.
In a preferred embodiment, the system for in vivo iodine contrast agent metabolism assessment and risk prevention comprises the following steps:
s1, the UPS power supply module in the iodine contrast agent risk prevention system provides the electric energy required by the operation for the interior of the iodine contrast agent risk prevention system, and at the moment, the iodine contrast agent risk prevention system starts to operate normally and detects the patient needing to be detected and prevented;
s2, after the iodine contrast agent detection module in the iodine contrast agent risk prevention system detects the content of iodine element in the body of the patient, the detection result is fed back to the inside of the data analysis module, and after the inside of the data analysis module receives the signal transmitted by the iodine contrast agent detection module, the data is analyzed, and the result obtained by analysis is transmitted to the inside of the power supply module;
s3, the data recording module II sends the data information to the inside of the data output end, the inside of the data output end transmits the data obtained by analysis to the inside of the data recording module I, and the data recording module I sends the information to the inside of the data sending module after the data is recorded;
and S4, the data sending module transmits the data to the inside of the information receiving end through the wireless transmission module, the information receiving end can display the data analysis result of the iodine-iodine contrast agent which is possibly dangerous in the human body outside the terminal display module, and the patient and the medical staff can perform further treatment measures according to the display result of the terminal display module.
In conclusion, due to the adoption of the technical scheme, the invention has the beneficial effects that:
1. in the invention, the wireless transmission module is matched with the iodine contrast agent detection module and the iodine contrast agent risk prevention system, so that people and medical personnel can timely monitor and prevent the content of the iodine contrast agent in the body, the iodine contrast agent is not required to be manually detected, the labor burden of the medical personnel is reduced, the medical personnel can more intensely deal with other medical problems, and meanwhile, the wireless transmission module can timely send information to the information receiving ends of the medical personnel and patients and the inside of the terminal display module, so that the patients can timely know the state of the illness, the working efficiency is improved, and the patients have sufficient time to deal with the illness.
2. In the invention, the UPS power supply module is adopted in the power supply module, so that the interior of the iodine contrast agent risk prevention system cannot be powered off, the stability of the system is increased, and the normal operation of the system is ensured, thereby benefiting more patients.
Drawings
FIG. 1 is a block diagram of the system of the present invention;
fig. 2 is a block diagram of the internal system of the iodine contrast agent risk prevention system of the present invention.
The labels in the figure are: the system comprises an iodine contrast agent risk prevention system 1, a power supply module 2, a data input module 3, a data recording module I4, a data sending module 5, a wireless transmission module 6, an information receiving end 7, a terminal display module 8, a control module 9, an iodine contrast agent detection module 10, a data analysis module 11, a data recording module II 12 and a data output end 13.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Referring to fig. 1-2, a system for evaluating the in vivo metabolism of iodine contrast agent and preventing risks comprises an iodine contrast agent risk prevention system 1, a power supply module 2, a data input module 3, a data recording module I4, a data sending module 5, a wireless transmission module 6, an information receiving end 7, a terminal display module 8 and a control module 9, wherein the input end of the iodine contrast agent risk prevention system 1 is connected with the output end of the power supply module 2, the power supply module 2 is internally provided with a UPS power supply module, and an Uninterruptible Power Supply (UPS) is a high-reliability and high-performance power supply necessary for a computer, a communication system and a situation requiring to be uninterrupted; the input of alternating current commercial power is changed into direct current through a rectifier, one part of energy is charged to a storage battery pack, the other part of energy is changed into alternating current through an inverter, and the alternating current is transmitted to a load through a change-over switch; in order to still provide energy for the load when the inverter fails, the other path of standby power supply is realized through a power supply changeover switch; modern UPS generally adopts pulse width modulation technology and modern power electronic devices such as power M0SFET, IGBT and the like, so that the noise of a power supply is reduced, and the efficiency and the reliability are improved; the introduction of the microprocessor software and hardware technology can realize intelligent management of the UPS, and remote maintenance and remote diagnosis are carried out; the iodine contrast agent analyzer of the internal social resource of the iodine contrast agent risk prevention system 1 can analyze the iodine contrast agent in the human body; iodine is a necessary trace element of a human body including all animals, and the content of the iodine element in the human body directly influences the health of the human body; iodine is an essential trace element of human bodies including all animals, is one of halogen elements, has the weakest chemical activity in the halogen elements, can be directly combined with most elements, and is widely existed in the nature in a compound form; iodine is slightly soluble in water, and stable hypoiodic acid generated by hydrolysis can make a brown yellow aqueous solution acidic; iodine is easily dissolved in organic solvents such as ethanol, diethyl ether, glycerol, etc.; the iodine is blue when meeting starch, so that qualitative and quantitative detection can be carried out; the iodine contrast agent in the seaweed is most abundant and is a main raw material for extracting pure iodine; iodine is also derived from seaweed in industry, and is mainly used for medicines, fuels, photosensitive materials, chemical reagents and the like; the input end of the data recording module I4 is connected with the output end of the iodine contrast agent risk prevention system 1, the input end of the data sending module 5 is connected with the output end of the data recording module I4, and a data acquisition and recording module adopting an RS232 serial port anti-SD card is arranged inside the data recording module I4; storing and analyzing; the weighing instrument is used for data acquisition, storage and analysis; the SD card data acquisition and recording module is very convenient to use, only a single chip microcomputer, a PLC or other instrument equipment with an RS232 communication function is needed to send a command string consisting of a string of ASCII codes to the module plus a field data string to be recorded in the SD card, and data are recorded in the SD card of the module; the data records recorded in the SD card are stored in a TXT file format, each record is a line, and each line of data is stored in a predefined fixed format; the TXT file can be copied to a computer for reference, reading and analysis; the input end of the wireless transmission module 6 is connected with the output end of the data sending module 5, the inside of the wireless transmission module 6 adopts a wireless SmartAir transmission technology, and the SmartAir technology is the only single-antenna mode gigabit wireless high-speed transmission technology in the communication industry; the method adopts the multiband OFDM air interface technology, the TDMA low-delay scheduling technology, the low-density parity check code LDPC, the adaptive modulation coding AMC, the hybrid automatic repeat HARQ and other advanced wireless communication technologies to realize the transmission rate reaching 1 Gbps; the input end of the information receiving end 7 is connected with the output end of the wireless transmission module 6, the inside of the information receiving end 7 comprises a receiving end used by medical staff and a mobile information receiving end used by a patient, and the receiving end can be a mobile phone, an electronic computer, a tablet computer and the like; the input end of the terminal display module 8 is connected with the output end of the information receiving end 7, a data display screen and an operation key are fixedly arranged outside the terminal display module 8, a liquid crystal module, a control panel and an inverter are arranged inside the data display screen, and the control panel plays a role in signal conversion; converting signals of various input formats into signals of a fixed output format; for example, the screen input signal for 1024 × 768 may be 640 × 480, 800 × 600, 1024 × 768, etc., eventually converted to output format 1024 × 768; the input end of the iodine contrast agent risk prevention system 1 is connected with the output ends of the control module 9 and the data input module 3;
iodine contrast agent risk prevention system 1's inside is provided with iodine contrast agent detection module 10, data analysis module 11, two 12 and data output end 13 of data record module, and data output end 13's input is connected with two 12's of data record module output, and the input of two 12 of data record module is connected with data analysis module 11's output, and data analysis module 11's input is connected with iodine contrast agent detection module 10's output. The operation of the system for evaluating the in-vivo metabolism of the iodine contrast agent and preventing risks comprises the following steps:
s1, the UPS power supply module in the iodine contrast agent risk prevention system 1 provides the electric energy required by the operation for the interior of the iodine contrast agent risk prevention system 1, at the moment, the iodine contrast agent risk prevention system 1 starts to operate normally, and the patient needing to be detected and prevented is detected;
s2, after the iodine contrast agent detection module 10 in the iodine contrast agent risk prevention system 1 detects the content of iodine element in the patient, the detection result is fed back to the inside of the data analysis module 11, and after the inside of the data analysis module 11 receives the signal transmitted by the iodine contrast agent detection module 10, the data is analyzed, and the result obtained by analysis is transmitted to the inside of the power supply module 2;
s3, the second data recording module 12 sends the data information to the inside of the data output end 13, the inside of the data output end 13 transmits the analyzed data to the inside of the first data recording module 4, and the first data recording module 4 sends the information to the inside of the data sending module 5 after the data is recorded;
and S4, the data sending module 5 transmits the data to the inside of the information receiving end 7 through the wireless transmission module 6, the information receiving end 7 displays the data analysis result of the iodine-iodine contrast agent which is possibly dangerous in the human body outside the terminal display module 8, and the patient and the medical staff can perform further processing measures according to the display result of the terminal display module 8.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions and improvements made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (8)
1. The utility model provides a be used for internal metabolism of iodine contrast agent to assess and risk prevention system, includes iodine contrast agent risk prevention system (1), power module (2), data input module (3), data record module (4), data transmission module (5), wireless transmission module (6), information receiving terminal (7), terminal display module (8), control module (9), its characterized in that: the input end of the iodine contrast agent risk prevention system (1) is connected with the output end of the power supply module (2), the input end of the data recording module I (4) is connected with the output end of the iodine contrast agent risk prevention system (1), the input end of the data sending module (5) is connected with the output end of the data recording module I (4), the input end of the wireless transmission module (6) is connected with the output end of the data sending module (5), the input end of the information receiving end (7) is connected with the output end of the wireless transmission module (6), the input end of the terminal display module (8) is connected with the output end of the information receiving end (7), and the input end of the iodine contrast agent risk prevention system (1) is connected with the output ends of the control module (9) and the data input module;
the iodine contrast agent risk prevention system (1) is internally provided with an iodine contrast agent detection module (10), a data analysis module (11), a second data recording module (12) and a data output end (13), the input end of the data output end (13) is connected with the output end of the second data recording module (12), the input end of the second data recording module (12) is connected with the output end of the data analysis module (11), and the input end of the data analysis module (11) is connected with the output end of the iodine contrast agent detection module (10).
2. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: the iodine contrast agent analyzer for the internal social resource of the iodine contrast agent risk prevention system (1) can analyze the iodine contrast agent in the human body; iodine is an essential trace element of a human body (including all animals), and the content of the iodine element in the human body directly influences the health of the human body; iodine is an essential trace element of human bodies (including all animals), is one of halogen elements, has the weakest chemical activity, can be directly combined with most elements, and is widely existed in the nature in a compound form; iodine is slightly soluble in water, and stable hypoiodic acid generated by hydrolysis can make a brown yellow aqueous solution acidic; iodine is easily dissolved in organic solvents such as ethanol, diethyl ether, glycerol, etc.; the iodine is blue when meeting starch, so that qualitative and quantitative detection can be carried out; the iodine contrast agent in the seaweed is most abundant and is a main raw material for extracting pure iodine; iodine is also derived from algae in industry, and is mainly used in medicine, fuel, photosensitive material, chemical reagent, etc.
3. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: an SD card-proof data acquisition and recording module adopting an RS232 serial port is arranged inside the data recording module I (4); storing and analyzing; the weighing instrument is used for data acquisition, storage and analysis; the SD card data acquisition and recording module is very convenient to use, only a single chip microcomputer, a PLC or other instrument equipment with an RS232 communication function is needed to send a command string consisting of a string of ASCII codes to the module plus a field data string to be recorded in the SD card, and data are recorded in the SD card of the module; the data records recorded in the SD card are stored in a TXT file format, each record is a line, and each line of data is stored in a predefined fixed format; the TXT file can be copied to a computer for review, reading and analysis.
4. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: a UPS power supply module is arranged in the power supply module (2), and the UPS is a high-reliability and high-performance power supply which is necessary for a computer, a communication system and a situation requiring to be provided and cannot be interrupted; the input of alternating current commercial power is changed into direct current through a rectifier, one part of energy is charged to a storage battery pack, the other part of energy is changed into alternating current through an inverter, and the alternating current is transmitted to a load through a change-over switch; in order to still provide energy for the load when the inverter fails, the other path of standby power supply is realized through a power supply changeover switch; modern UPS generally adopts pulse width modulation technology and modern power electronic devices such as power M0SFET, IGBT and the like, so that the noise of a power supply is reduced, and the efficiency and the reliability are improved; the introduction of the microprocessor software and hardware technology can realize intelligent management of the UPS, and remote maintenance and remote diagnosis.
5. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: the inside of the wireless transmission module (6) adopts a wireless SmartAir transmission technology, and the SmartAir technology is the only single-antenna mode gigabit wireless high-speed transmission technology in the communication industry; the method adopts the multiband OFDM air interface technology, the TDMA low-delay scheduling technology, the low-density parity check code LDPC, the adaptive modulation coding AMC, the hybrid automatic repeat HARQ and other advanced wireless communication technologies to realize the transmission rate reaching 1 Gbps.
6. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: a data display screen and an operation key are fixedly arranged outside the terminal display module (8), and a liquid crystal module, a control panel and an inverter are arranged inside the data display screen, wherein the control panel plays a role in signal conversion; converting signals of various input formats into signals of a fixed output format; for example, the screen input signal for 1024x768 may be 640 x 480, 800 x 600, 1024x768, etc., ultimately converted to an output format of 1024x 768.
7. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: the information receiving end (7) comprises a receiving end used by medical staff and a mobile information receiving end used by a patient, and the receiving end can be a mobile phone, an electronic computer, a tablet computer and the like.
8. The system of claim 1 for in vivo metabolic evaluation and risk prevention of iodine contrast agents, wherein: the operation of the system for evaluating the in-vivo metabolism of the iodine contrast agent and preventing risks comprises the following steps:
s1, the UPS power supply module in the iodine contrast agent risk prevention system (1) provides the electric energy needed by the operation for the iodine contrast agent risk prevention system (1), at the moment, the iodine contrast agent risk prevention system (1) starts to operate normally, and the patient needing to be detected and prevented is detected;
s2, after the iodine contrast agent detection module (10) in the iodine contrast agent risk prevention system (1) detects the content of iodine in the body of a patient, the detection result is fed back to the inside of the data analysis module (11), and after the inside of the data analysis module (11) receives a signal transmitted by the iodine contrast agent detection module (10), the data is analyzed, and the result obtained by analysis is transmitted to the inside of the power supply module (2);
s3, the data recording module II (12) sends the data information to the inside of the data output end (13), the inside of the data output end (13) transmits the analyzed data to the inside of the data recording module I (4), and the data recording module I (4) sends the information to the inside of the data sending module (5) after the data is recorded;
s4, the data sending module (5) transmits the data to the inside of the information receiving end (7) through the wireless transmission module (6), the information receiving end (7) displays the data analysis result of the iodine-iodine contrast agent which is possibly dangerous in the human body outside the terminal display module (8), and the patient and the medical staff can carry out further processing measures according to the display result of the terminal display module (8).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010937516.4A CN112641427A (en) | 2020-09-08 | 2020-09-08 | System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010937516.4A CN112641427A (en) | 2020-09-08 | 2020-09-08 | System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112641427A true CN112641427A (en) | 2021-04-13 |
Family
ID=75346210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010937516.4A Pending CN112641427A (en) | 2020-09-08 | 2020-09-08 | System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112641427A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2314424Y (en) * | 1997-12-08 | 1999-04-14 | 上海医科大学附属华山医院 | Apparatus for simulating curves of in vivo media changes |
| US20150127376A1 (en) * | 2012-05-08 | 2015-05-07 | Mallinckrodt Llc | Contrast media injection data management |
| CN110507330A (en) * | 2019-08-21 | 2019-11-29 | 苏州华墨信息科技有限公司 | It is a kind of for supporting the remote supervision system of CRRT |
| CN110702888A (en) * | 2019-09-19 | 2020-01-17 | 中国人民解放军总医院第八医学中心 | Liver and kidney clearance detection method for two isomers of Pumei |
| CN110960748A (en) * | 2019-11-06 | 2020-04-07 | 中国人民解放军陆军军医大学第一附属医院 | Alarm control device for monitoring extravasation of contrast agent |
-
2020
- 2020-09-08 CN CN202010937516.4A patent/CN112641427A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2314424Y (en) * | 1997-12-08 | 1999-04-14 | 上海医科大学附属华山医院 | Apparatus for simulating curves of in vivo media changes |
| US20150127376A1 (en) * | 2012-05-08 | 2015-05-07 | Mallinckrodt Llc | Contrast media injection data management |
| CN110507330A (en) * | 2019-08-21 | 2019-11-29 | 苏州华墨信息科技有限公司 | It is a kind of for supporting the remote supervision system of CRRT |
| CN110702888A (en) * | 2019-09-19 | 2020-01-17 | 中国人民解放军总医院第八医学中心 | Liver and kidney clearance detection method for two isomers of Pumei |
| CN110960748A (en) * | 2019-11-06 | 2020-04-07 | 中国人民解放军陆军军医大学第一附属医院 | Alarm control device for monitoring extravasation of contrast agent |
Non-Patent Citations (1)
| Title |
|---|
| 任克等: "碘对比剂诱导急性肾损伤研究进展", 《中国医学影像技术》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN201135495Y (en) | Multi-network multi-parameter health supervision system | |
| CN203369897U (en) | Human body physiological parameter monitoring system based on intelligent terminal communications | |
| CN103313651A (en) | Self-contained patient monitor | |
| CN202614773U (en) | Portable urine analyzer | |
| CN202568244U (en) | Portable wireless electrocardio monitoring management system | |
| CN209883229U (en) | Personnel safety monitoring and accurate positioning wrist under industrial environment | |
| CN112641427A (en) | System for evaluating in-vivo metabolism of iodine contrast agent and preventing risks | |
| CN204600521U (en) | A kind of recuperation of the house based on heart sound analysis heart patient remote monitoring system | |
| CN103501256B (en) | A kind of method testing interchangeability of local communication unit of electric energy meter | |
| CN205041399U (en) | Intelligent electrocardiogram monitoring system | |
| CN213488781U (en) | Medical monitor capable of automatically detecting environment in ward | |
| CN202843599U (en) | Pulse remote detection control device based on Zigbee network | |
| CN203524657U (en) | Intelligent monitoring terminal of human physiological indexes | |
| CN201919035U (en) | Internet-of-Things wireless multi-parameter acquisition medical monitoring system | |
| CN202837291U (en) | Intrinsic safety type wireless methane sensor based on zigbee | |
| CN203632664U (en) | Portable fault detector for remote power-collecting system equipment | |
| CN202127442U (en) | Mobile phone with blood sugar meter | |
| CN211718722U (en) | AED intelligent monitoring case device | |
| CN202665523U (en) | Electrocardiograph with wireless communication function | |
| CN201398967Y (en) | Cardiac monitoring system based on bluetooth phone | |
| CN112472313A (en) | Intelligent medical waste recovery terminal | |
| CN216061118U (en) | Negative pressure isolation cabin data remote transmission system | |
| CN202067279U (en) | Small-size electronic physiological monitoring system with function of heart frequency spectrum | |
| CN211409042U (en) | Patient monitoring device in hospital ward | |
| CN201905890U (en) | Single electrocardiograph remote sensing monitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210413 |